BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 13 June 2007. doi:10.1136/bjo.2007.121830
British Journal of Ophthalmology 2007;91:1602-1606
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
bjo.2007.121830v1
91/12/1602    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, S J
Right arrow Articles by Grossniklaus, H E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, S J
Right arrow Articles by Grossniklaus, H E

SCIENTIFIC REPORT

Histopathological findings in postmortem eyes after photodynamic therapy for choroidal neovascularisation in age-related macular degeneration: report of two cases

S J Kang1, I Schmack2, H E Benson1, H E Grossniklaus1

1 Department of Ophthalmology, Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA
2 Department of Ophthalmology, Ruprecht-Karls-University, Heidelberg, Germany

Correspondence to:
H E Grossniklaus, LF Montgomery Ophthalmic Pathology Laboratory, Emory Eye Center, 1365-B Clifton Road NE, Atlanta, GA 30322, USA; ophtheg{at}emory.edu


ABSTRACT
Background: To report the histopathological findings after photodynamic therapy (PDT) in eyes obtained postmortem with choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD).

Methods: Two eyes were obtained postmortem from two patients with CNV secondary to AMD. Both of the patients had been treated with PDT. Serial sections through the posterior poles were obtained and stained with haematoxylin-eosin, periodic acid-Schiff, Masson trichrome or phosphotungstic acid haematoxylin (PTAH). Two-dimensional reconstructions were prepared and compared with fluorescein angiograms.

Results: The interval between PDT and death was 3 months and 17 months in each patient, respectively. Light-microscopic examination showed that CNV enveloped with retinal pigment epithelium (RPE) in both eyes. The average size of the CNV was 550x280 µm. One eye had combined (subRPE/subretinal) growth pattern CNV, and the other eye had both type I (subRPE) and combined growth pattern CNV. All specimens contained fibrous proliferation and patent vascular channels within the CNV, and there was no thrombus formation within the vascular channels. No apparent abnormalities in the choroid were observed by light microscopy.

Conclusions: Although involution with fibrous tissue proliferation occurred, PDT did not result in permanent occlusion of the vascular channels in the CNV. Our findings indicate that PDT may accelerate involution of CNV, thus limiting its size and preserving photoreceptors.


Abbreviations: AMD, age-related macular degeneration; CNV, choroidal neovascularisation; IOL, intraocular lens; PDT, photodynamic therapy; PTAH, phosphotungstic acid haematoxylin; RPE, retinal pigment epithelium


FOOTNOTES
Presented in part at the 2005 annual meeting of the Association for Research in Vision and Ophthalmology at Fort Lauderdale, Florida.

Competing interests: None.

Funding: HEG is a recipient of the Research to Prevent Blindness Senior Scientific Investigator award. This study was supported by a grant from QLT, Vancouver, BC, Canada. The sponsors participated in the study design, in the collection and in the decision to submit the paper for publication.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.